Attachment and Prognostic Factor: the Implicit Approach

ConditionDependence Addictive

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-65

SponsorCentre Hospitalier Henri Laborit

About this trial

This is a prospective longitudinal study aimed at better understanding the determinants of the prognosis of patients with substance dependence.

5 visits are planned during the study :

* the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online * 4 telephone interviews for follow-up by investigator.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients between 18 and 65 years old

Patients with a use-related disorder as defined by DSM5

Patients weaning for a substance, supported within the addictology sector of Henri Laborit Hospital

Having expressed non-opposition to participating in the study after receiving written information.

Disqualifiers

Person who cannot read or write

Simultaneous participation in a therapeutic trial involving oxytocin

Patients protected by law

Patients who do not have French as their native language

Trial population

Patients with a use-related disorder weaning for a substance, supported within the addictology sector of Henri Laborit Hospital

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Questionnaires
Behavioral
5 visits are planned during the study : * the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online * 4 telephone interviews for follow-up by investigator

Treatment groups

200 Participants

are divided into 1 treatment group

Group A: Patients with a use-related disorder weaning for a substance1 intervention

Trial outcomes

Primary outcomes

Implicit attachment and onsumption

Assessment of the link between implicit attachment and changes in consumption after a 12-month follow-up

Time frame

12 months

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Centre Hospitalier Henri Laborit

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: